Table 1 Clinical and demographic characteristics of the participants at baseline
SSc patients (N = 21) | Controls (N = 15) | |
|---|---|---|
Female,n(%) | 18 (85.7) | 11 (73.3) |
Age (years) | 58.0 (48.5–63.0) | 55.0 (45.0–63.0) |
Smoking habits,n(%) | ||
Never | 17 (80.9) | 11 (73.3) |
Ex-smoker | 4 (19.1) | 4 (26.6) |
Disease duration since diagnosis, years | 10.0 (5.5–14.0) | – |
Disease duration since RP, years | 14.0 (6.5–16.5) | – |
Limited form,n(%) | 12 (57.1) | – |
mRSS total | 8.0 (4.0–15.0) | – |
Phase,n(%) | – | |
Oedematous | 5 (23.8) | |
Fibrotic | 16 (76.2) | |
ANA positive,n(%) | 20 (95.2) | – |
ACA positive,n(%) | 9 (42.9) | – |
Anti-Scl 70 positive,n(%) | 7 (33.3) | – |
Immunosuppressive treatmenta(yes),n(%) | 6/21 | – |
Vasodilators treatmentb(yes),n(%) | 9/21 | – |